$CARE

Carter Bankshares, Inc. (CARE): Results of Operations and Financial Condition

Carter Bankshares, Inc. (CARE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 care-2q26_ex991xer.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE – July 23, 2026 Carter Bankshares, Inc. Announces Second Quarter 2026 Financial Results Martinsville, VA, July 23, 2026 – Carter Bankshares, Inc. (the “Company”) (NASDAQ:CARE), the holding compan

Original reporting
Published Jul 23, 2026, 12:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 12:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CARE
Neutral
medium confidence
Mentioned
$CARE
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CARENeutralMed
01

Why it matters

Key disclosed drivers are (1) GAAP earnings swing versus prior quarter, (2) NIM expansion to 3.38%, (3) sequential NPL increase to $37.6M (1.01% of loans), and (4) a portfolio repositioning that sold lower-yield securities (2.28% avg) and bought higher-yield AAA/AA securities (5.27% avg), expected to enhance future earnings.

02

Market read

Traders will likely focus on the earnings composition (nonrecurring gains), the sustainability of NIM gains, and the direction of credit quality after a sequential NPL increase.

03

What to watch

Credit metrics worsened sequentially due to one downgraded C&I relationship, so traders should watch whether NPLs normalize in subsequent quarters and whether the higher-yield AFS purchases translate into sustained NIM without further credit deterioration.

Relevance 7/10Novelty 7/10Timing: after-hours SEC 8-K filing for Q2 2026 results

Background

The 8-K (Item 2.02) reports Q2 2026 financial results and discusses balance-sheet actions including the Bearing Insurance Group sale and an AFS securities portfolio repositioning.

Company-level read

Ticker impact

$CARENeutralMedium confidence
Context

Carter Bankshares reported Q2 2026 net income of $28.9M and EPS $1.31, plus a $35.9M pre-tax gain from selling Bearing Insurance Group.

Expected impact

Near-term volatility likely driven by the earnings swing and the disclosed nonrecurring items, with focus shifting to whether NIM and credit quality stabilize.

Evidence & confidence

The filing provides concrete quarterly and six-month figures, NIM expansion, NPL deterioration linked to one downgraded C&I relationship, and a detailed AFS securities swap into higher-yield AAA/AA assets.

Market effects

Regional bank investors may reprice credit risk and NIM sustainability based on disclosed NPL movement and AFS yield repositioning.

Limited to the company’s footprint, but credit-quality deterioration in a single C&I relationship can influence sentiment toward similar regional exposures.

Low. This is company-specific earnings and balance-sheet management with no direct global macro linkage.

Counterpoint

The headline net income decline may overstate underlying operating weakness because adjusted net income is much closer to prior-quarter levels and nonrecurring gains distort GAAP comparability.

Key entities

  • Carter Bankshares, Inc.

    NASDAQ-listed holding company reporting Q2 2026 results and balance-sheet repositioning actions.

  • Bearing Insurance Group, LLC

    Insurance Transaction sold effective May 1, 2026, generating a $35.9M pre-tax gain and EPS accretion.

Related articles

$HYMed

Hyster-Yale’s (HY) Bookings Boom Meets A Widening Loss

Hyster-Yale (HY) reported Q2 results with bookings up 106% YoY to $680M, but a net loss of $31.6M. Revenue rose 2% QoQ to $812.9M, and operating cash flow turned positive at $17M. Management expects full-year bookings to exceed 2025, but warns of slow margin recovery due to competitive pricing and tariffs.

$MNDYHighAI 8/10

Why Monday.com Stock Popped in August

Monday.com (MNDY) stock rose 16% in August, despite initial investor concerns over its Q2 results. Revenue grew 22% YoY to $365M, and adjusted net income increased 13% to $65.6M. The company provided optimistic guidance for Q3 and 2026. A strong earnings report from Salesforce later in the month boosted investor sentiment in the CRM sector, benefiting Monday.com.

$AQSTMed

Aquestive Therapeutics (AQST): Second Chance At Anaphylm Comes Into Focus

Aquestive Therapeutics (AQST) reported Q2 2026 results, staying on track to resubmit Anaphylm epinephrine film to the FDA in Q3 2026. Studies addressed FDA concerns, with improved packaging and labeling. Revenue rose 38% to $13.8M, but net loss widened to $22.9M. Cash reserves stand at $98.5M. The company also advanced its epinephrine prodrug platform and manufacturing business.

$CRMDMedAI 8/10

CorMedix (CRMD) Just Tripled Its Profits, But Guidance Barely Budged

CorMedix (CRMD) reported Q2 revenue of $101.9M, up from $39.7M a year ago, with net income of $26M. Management raised adjusted EBITDA guidance but kept full-year revenue guidance unchanged. DefenCath and the Melinta portfolio drove growth, with new supply agreements signed. The company expects to submit an sNDA for REZZAYO in Q3. Operating expenses increased due to Melinta's costs and R&D spending. Hedge fund ownership rose, while short interest remained high at 22.30%.

$CCSIMed

Consensus Cloud’s (CCSI) Buyback Doubles, But Growth Has A Catch

Consensus Cloud Solutions (CCSI) reported Q2 revenue of $91.4M, up 4.1%, and net income of $27.4M, up 31.7%. The board doubled its buyback authorization to $200M. Corporate segment revenue rose 9.3%, while the SoHo business declined 4.7%. Adjusted EBITDA was flat at $48.3M. The company reaffirmed its 2026 guidance and issued steady Q3 guidance.